2023
Baseline skin cytokine profiles determined by RNA in situ hybridization correlate with response to dupilumab in patients with eczematous dermatitis
Singh K, Valido K, Swallow M, Okifo K, Wang A, Cohen J, Damsky W. Baseline skin cytokine profiles determined by RNA in situ hybridization correlate with response to dupilumab in patients with eczematous dermatitis. Journal Of The American Academy Of Dermatology 2023, 88: 1094-1100. PMID: 36780951, DOI: 10.1016/j.jaad.2022.12.052.Peer-Reviewed Original ResearchMeSH KeywordsAntibodies, MonoclonalCytokinesDermatitis, AtopicEczemaHumansIn Situ HybridizationInterleukin-13Retrospective StudiesSeverity of Illness IndexTreatment OutcomeConceptsEczematous dermatitisHistologic featuresTreatment selectionType 1Type 3 inflammationInflammatory skin diseaseCertain histologic featuresSitu hybridization correlatesClinical responseNonresponder groupCytokine profileCytokine stainingAtopic dermatitisCytokine RNAEczematous disordersSitu hybridizationDupilumabIL13 expressionSkin diseasesType 2PatientsDermatitisNonrespondersMolecular heterogeneityImproved response
2022
Migraine among adults with atopic dermatitis: a cross-sectional study in the All of Us research programme
Fan R, Leasure A, Damsky W, Cohen J. Migraine among adults with atopic dermatitis: a cross-sectional study in the All of Us research programme. Clinical And Experimental Dermatology 2022, 48: 24-26. PMID: 36669173, DOI: 10.1093/ced/llac004.Peer-Reviewed Original ResearchMeSH KeywordsAdolescentAdultChildComorbidityCross-Sectional StudiesDermatitis, AtopicHumansMigraine DisordersPopulation HealthSeverity of Illness Index
2020
Systemic treatment of psoriasis and psoriatic arthritis in the United States: a cross-sectional study
Steuer AB, Wang JF, Feng H, Cohen JM. Systemic treatment of psoriasis and psoriatic arthritis in the United States: a cross-sectional study. Journal Of Dermatological Treatment 2020, 33: 1193-1194. PMID: 32715842, DOI: 10.1080/09546634.2020.1795059.Peer-Reviewed Original ResearchMeasurement properties of instruments assessing psoriatic arthritis symptoms for psoriasis clinical trials: a systematic literature review
Perez-Chada LM, Balak D, Cohen JM, Ogdie A, Merola JF, Gottlieb AB. Measurement properties of instruments assessing psoriatic arthritis symptoms for psoriasis clinical trials: a systematic literature review. Expert Review Of Clinical Immunology 2020, 16: 267-283. PMID: 32037912, DOI: 10.1080/1744666x.2020.1724090.Peer-Reviewed Original ResearchMeSH KeywordsArthritis, PsoriaticClinical Trials as TopicHumansOutcome Assessment, Health CarePsoriasisQuality of LifeSeverity of Illness IndexConceptsPatient global assessmentInternational Dermatology Outcome MeasuresPsoriatic arthritis symptomsPsoriasis clinical trialsArthritis symptomsQuality evidenceClinical trialsMeasurement propertiesContent validityRisk of biasMeasurement of painLevel of evidencePsA ImpactPsA symptomsGlobal assessment instrumentsFurther validation studiesDisease 9Physical functionOutcome measuresEligible articlesCOSMIN checklistGlobal assessmentSymptomsSymptom measuresPsAID12
2019
Measuring psoriatic arthritis symptoms: A core domain in psoriasis clinical trials
Perez-Chada LM, Gottlieb AB, Cohen J, Mease P, Duffin KC, Garg A, Latella J, Armstrong AW, Ogdie A, Merola JF. Measuring psoriatic arthritis symptoms: A core domain in psoriasis clinical trials. Journal Of The American Academy Of Dermatology 2019, 82: 54-61. PMID: 31163240, DOI: 10.1016/j.jaad.2019.05.075.Peer-Reviewed Original ResearchConceptsPsA symptomsPsoriasis trialsOutcome measuresConsensus meetingPatient Index Data 3International Dermatology Outcome MeasuresPatient association representativesPsoriatic Arthritis ImpactPsoriatic arthritis symptomsPsoriasis clinical trialsAppropriate outcome measuresConsensus-building studyDelphi surveyPSA screeningArthritis ImpactArthritis symptomsPsoriatic arthritisDisease 9Psoriasis studiesClinical trialsTrial participantsSymptomsQuality appraisalAcceptable alternativeData 3The ALT-70 cellulitis model maintains predictive value at 24 and 48 hours after presentation
Singer S, Li DG, Gunasekera N, Okhovat JP, Vedak P, Weng C, Cohen J, Joyce C, Raff A, Kroshinsky D, Mostaghimi A. The ALT-70 cellulitis model maintains predictive value at 24 and 48 hours after presentation. Journal Of The American Academy Of Dermatology 2019, 81: 1252-1256. PMID: 30914341, DOI: 10.1016/j.jaad.2019.03.050.Peer-Reviewed Original Research
2017
A predictive model for diagnosis of lower extremity cellulitis: A cross-sectional study
Raff AB, Weng QY, Cohen JM, Gunasekera N, Okhovat JP, Vedak P, Joyce C, Kroshinsky D, Mostaghimi A. A predictive model for diagnosis of lower extremity cellulitis: A cross-sectional study. Journal Of The American Academy Of Dermatology 2017, 76: 618-625.e2. PMID: 28215446, DOI: 10.1016/j.jaad.2016.12.044.Peer-Reviewed Original ResearchConceptsLower extremity cellulitisExtremity cellulitisDiagnosis of cellulitisCross-sectional studyCross-sectional reviewWidespread clinical useTrue cellulitisClinical mimickersEmergency departmentFrequent misdiagnosisAlternative diagnosesFinal diagnosisProspective validationCellulitisPatient careAccurate diagnosisLeukocytosisClinical useTachycardiaPatientsDiagnosisLarge hospitalsBivariate associationsPseudocellulitisAge
2015
Epidemiology of concomitant psoriasis and hidradenitis suppurativa (HS): Experience of a tertiary medical center
Patel M, Cohen JM, Wright NA, Merola JF, Qureshi AA, Vleugels RA. Epidemiology of concomitant psoriasis and hidradenitis suppurativa (HS): Experience of a tertiary medical center. Journal Of The American Academy Of Dermatology 2015, 73: 701-702. PMID: 26369843, DOI: 10.1016/j.jaad.2015.06.050.Peer-Reviewed Original Research